iMDsoft Announces that United States Patent Office Orders Second Re-Examination of Visicu Patent

Business Wire, Feb 16, 2007

BOSTON -- In response to a formal request filed by iMDsoft, the United States Patent and Trademark Office (USPTO) ordered re-examination of a health care services patent owned by Visicu, Inc. The USPTO found that prior art provided in iMDsoft's request raises "a substantial new question of patentability" regarding all twenty-six claims of Visicu's patent. This prior art includes iMDsoft's own patent disclosure, which pre-dates Visicu's patent. All of the claims in Visicu's patent are affected.

This is the second time the USPTO has decided to re-examine Visicu's patent, U.S. Patent No. 6,804,656, entitled "System and Method for Providing Continuous, Expert Network Critical Care Services from a Remote Location(s)." On April 7, 2005 a first re-examination of Visicu's patent was order by the USPTO in response to a request filed by iMDsoft. The first re-examination ended with Visicu being forced to change its claims to have a narrower scope. According to recently compiled statistics by the USPTO, over 70% of re-examinations are successful in having a patent narrowed or completely revoked.

"We are encouraged by the USPTO decision and feel confident that this process will eliminate any remaining concerns of Medical Centers implementing remote critical care programs." says Phyllis Gotlib, iMDsoft's CEO. "Our MVCentral solution is an important part of our comprehensive critical care platform. Together, the MetaVision suite of products provide our client partners with the flexibility to dynamically and efficiently leverage their resources at the bedside and also in remote, distributed and centralized locations. We always believed that remote care must be tightly integrated with robust bed-side solution".

iMDsoft has invested significant time and funds to develop its own intellectual property portfolio. In fact, the invention in iMDsoft's first patent predates Visicu's patent by several years. Along with a forward looking vision, iMDsoft's intellectual property portfolio provides direction for developing products, and for developing ground-breaking services through cooperation with its customers and partners alike.

About iMDsoft

Founded in 1996, iMDsoft is leading the critical care Clinical Information and Anesthesia Information Management Systems marketplace, supporting the complete continuum of care in intensive care and perioperative environments including "tele-monitoring" programs. iMDsoft 's MetaVision Suite, first implemented in 1999, is a family of products designed to capture, integrate and analyze critical care information enabling improvements in patient care and more effective use of resources. The company - headquartered in Massachusetts and with offices in Europe, Israel, and Japan - is globally recognized for its innovative products and world-class service and support. MetaVision systems are successfully implemented in leading healthcare institutions across three continents.